JW Shinyak Corporation (KOSDAQ:067290)
1,869.00
-110.00 (-5.56%)
At close: Apr 2, 2026
JW Shinyak Revenue
In the year 2025, JW Shinyak had annual revenue of 81.04B KRW, down -12.87%. JW Shinyak had revenue of 21.10B in the quarter ending December 31, 2025, with 31.22% growth.
Revenue
81.04B
Revenue Growth
-12.87%
P/S Ratio
1.38
Revenue / Employee
442.86M
Employees
183
Market Cap
111.75B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 81.04B | -11.97B | -12.87% |
| Dec 31, 2024 | 93.01B | -11.22B | -10.77% |
| Dec 31, 2023 | 104.23B | 1.52B | 1.48% |
| Dec 31, 2022 | 102.71B | 1.74B | 1.73% |
| Dec 31, 2021 | 100.97B | -2.84B | -2.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| KM Corporation | 135.41B |
| Sewoon Medical | 63.66B |
| CG MedTech | 47.23B |
| OSTEONIC | 45.39B |
| DuChemBIO | 38.57B |
| Wonbiogen | 34.38B |
| Billions | 25.31B |
| SCL Science | 16.32B |